UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ
批准号:
7951566
负责人:
TIMOTHY CLOUGHESY
金额:
$17.02万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2009-11-30
关键词:
Clinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseDNAEvaluationFreezingFundingGlioblastomaGrantInstitutionNewly DiagnosedPatientsPhase II Clinical TrialsProteinsRadiationResearchResearch Ethics CommitteesResearch PersonnelResourcesSafetySamplingSourceUnited States National Institutes of Healthbevacizumabtemozolomidetumor
中文摘要
这个子项目是许多利用
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
中心,但不一定是研究者所在的机构。
具体目标:
主要目的
研究贝伐珠单抗联合替莫唑胺/放疗在新诊断胶质母细胞瘤患者中的安全性和耐受性
估计接受贝伐珠单抗/替莫唑胺/放疗后接受贝伐珠单抗/替莫唑胺治疗2年或直至检测到进展的新诊断胶质母细胞瘤受试者的总生存期。
次要目的
进一步研究贝伐珠单抗/替莫唑胺/放疗后贝伐珠单抗/替莫唑胺的安全性和耐受性。
从冷冻和石蜡化存档肿瘤样本中分离DNA、RNA和蛋白质,以进行评价。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
SPECIFIC AIMS:
Primary Aim
To investigate the safety and tolerability in newly-diagnosed patients with glioblastoma of the combination of bevacizumab with temozolomide/radiation
To estimate the overall survival in subjects with newly-diagnosed glioblastoma treated with bevacizumab/temozolomide/radiation followed by bevacizumab/temozolomide for 2 years or until progression is detected.
Secondary Aims
To investigate further the safety and tolerability of bevacizumab/temozolomide/radiation followed by bevacizumab/temozolomide.
To isolate DNA, RNA, and protein isolated from frozen and paraffinized archival tumor samples for evaluations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
-
批准号:10590620
-
项目类别:
-
资助金额:$60.57万
-
财政年份:2022
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
-
批准号:10419491
-
项目类别:
-
资助金额:$62.3万
-
财政年份:2022
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
Career Enhancement Program
-
批准号:10225555
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2017
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
Career Enhancement Program
-
批准号:9983052
-
项目类别:
-
资助金额:$7.37万
-
财政年份:2017
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
UCLA IRB (PENDING) "A PHASE I/II STUDIES OF BAY 43-9006 (SORAFENIB) IN COMBIN
-
批准号:7951564
-
项目类别:
-
资助金额:$2.37万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
PHASE I/II STUDY OF OSI-774 (ERLOTINIB) AND CCI-779 (TEMSIROLIMUS) IN PATIENT
-
批准号:8167082
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
UCLA IRB # 06-04-104 "A PHASE I/II, DUAL-CENTER, OPEN-LABEL TRIAL OF THE SAFE
-
批准号:7951565
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
UCLA IRB # 06-04-016 "PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZ
-
批准号:8167096
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
UCLA IRB #05-12-061 "A PHASE I STUDY OF VORINOSTAT (SUBEROYLANILIDE HYDROXAMI
-
批准号:7951558
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
UCLA IRB 08-09-042: PHASE I TRIAL OF AFLIBERCEPT (VEGF TRAP) WITH RADIATION THE
-
批准号:8167134
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
PHASE II SINGLE ARM TRIAL OF VEGF TRAP IN PATIENTS WITH RECURRENT TEMOZOLOMIDE-
-
批准号:7951575
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
PHASE I/II STUDY OF OSI-774 (ERLOTINIB) AND CCI-779 (TEMSIROLIMUS) IN PATIENT
-
批准号:7951542
-
项目类别:
-
资助金额:$3.53万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
UCLA IRB # 06-04-104 "A PHASE I/II, DUAL-CENTER, OPEN-LABEL TRIAL OF THE SAFE
-
批准号:8167095
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2009
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
CONSORTIUM THERAPEUTIC STUDIES OF PRIMARY CENTRAL NERVI*
-
批准号:7724330
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2008
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
PHASE II TRIAL OF EMD 121974 FOR RECURRENT GLIOBLASTOMA: A CLINICAL TRIAL WIT
-
批准号:7606797
-
项目类别:
-
资助金额:$6.63万
-
财政年份:2007
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
A BIOMARKER AND PHASE II STUDY OF GW 572016 IN RECURRENT MALIGNANT GLIOMA (NA
-
批准号:7717990
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2007
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
CLINICAL TRIAL: A PHASE II TRIAL OF POLY-ICLC IN PATIENTS WITH RECURRENT ANAPLAS
-
批准号:7717972
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2007
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
UCLA IRB #05-12-061 "A PHASE I STUDY OF VORINOSTAT (SUBEROYLANILIDE HYDROXAMI
-
批准号:7606832
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2007
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
CONSORTIUM THERAPEUTIC STUDIES OF PRIMARY CENTRAL NERVI*
-
批准号:7627686
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2007
-
负责人:TIMOTHY CLOUGHESY
-
依托单位:
RECURRENT TEMOZOLOMIDE-RESISTANT MALIGNANT GLIOMAS
-
批准号:7718036
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2007
-
负责人:TIMOTHY CLOUGHESY
-
依托单位: